MICA, a gene contributing strong susceptibility to ankylosing spondylitis

Annals of the Rheumatic Diseases

Volumn 73, Issue 8, 2014, Pages 1552-1557

  Zhou, Xiaodong ^a   Wang, Jiucun ^b   Zou, Hejian ^c   Ward, Michael M ^d   Weisman, Michael H ^e   Espitia, Maribel G ^a   Xiao, Xiangjun ^f   Petersdorf, Effie ^g   Mignot, Emmanuel ^h   Martin, Javier ⁱ   Gensler, Lianne S ^j   Scheet, Paul ^f   Reveille, John D ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b FUDAN UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

^d NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^e CEDARS SINAI MEDICAL CENTER   (United States)

^f UNIVERSITY OF TEXAS   (United States)

^g UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^h STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^j UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; HLA B27 ANTIGEN;

ADULT; AMINO ACID SUBSTITUTION; ANKYLOSING SPONDYLITIS; ARTICLE; CAUCASIAN; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HAN CHINESE; HUMAN; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I CHAIN RELATED GENE A; MALE; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

ANKYLOSING SPONDYLITIS; GENE POLYMORPHISM; INFLAMMATION;

ADULT; ASIAN AMERICANS; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-B ANTIGENS; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; RISK FACTORS; SPONDYLITIS, ANKYLOSING; UNITED STATES;

EID: 84903904618     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2013-203352     Document Type: Article

References (32)

1. Braun J, Bollow M, Remlinger G, et al. Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum 1998;41:58-67. (Pubitemid 28041923)
2. Lawrence RC, Helmick CG, Arnett FC, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998;41:778-99. (Pubitemid 28225778)
3. Dai SM, Han XH, Zhao DB, et al. Prevalence of rheumatic symptoms, rheumatoid arthritis, ankylosing spondylitis, and gout in Shanghai, China: a COPCORD study. J Rheumatol 2003;30:2245-51.
4. Helmick CG, Felson DT, Lawrence RC, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States I. Arthritis Rheum 2008;58:15-25.
5. Malaviya AN, Mehra NK, Adhar G, et al. HLA B27 in patients with seronegative spondarthritides. J Rheumatol 1979;6:413-16. (Pubitemid 10227428)
6. Reveille JD, Hirsch R, Dillon CF, et al. The Prevalence of HLA-B27 in the United States: data from the U.S. National Health and Nutrition Examination Survey, 2009. Arthritis Rheum 2012;64:1407-11.
7. Australo-Anglo-American Spondyloarthritis Consortium (TASC). Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat Genet 2010;42:123-7.
8. Wellcome Trust Case Control Consortium; Australo-Anglo-American Spondylitis Consortium (TASC). Association scan of 14,500 nsSNPs in four common diseases identifies variants involved in autoimmunity. Nat Genet 2007;39:1329-37.
9. Australo-Anglo-American Spondyloarthritis Consortium (TASC) and the Wellcome Trust Case Control Consortium 2 (WTCCC2). Genome-wide association study in ankylosing spondylitis identifies further non-MHC associations, and demonstrates that the ERAP1 association is restricted to HLA-B27 positive cases implicating peptide presentation as the likely mechanism underlying the association of HLA-B27 with the disease. Nat Genet 2011;43:761-7.
10. Bauer S, Groh V, Wu J, et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999;285:727-9.
11. Ward MM, Weisman MH, Davis JC, et al. Risk factors for functional limitations in patients with long-standing ankylosing spondylitis. Arthritis Rheum 2005;53:710-17. (Pubitemid 41463836)
12. Zhang G, Luo J, Bruckel J, et al. Genetic studies in familial ankylosing spondylitis susceptibility. Arthritis Rheum 2004;50:2246-54. (Pubitemid 38924403)
13. Van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-8. (Pubitemid 14134775)
14. Field SF, Nejentsev S, Walker NM, et al. Sequencing-based genotyping and association analysis of the MICA and MICB genes in type 1 diabetes. Diabetes 2008;57:1753-6.
15. Moran D, Morishima S, Malkki M, et al. Identification of the MICA-070 allele by sequencing and phasing. Hum Immunol 2013;74:557-61.
16. Gonzalez S, Martinez-Borra J, Torre-Alonso JC, et al. The MICA-A9 triplet repeat polymorphism in the transmembrane region confers additional susceptibility to the development of psoriatic arthritis and is independent of the association of Cw*0602 in psoriasis. Arthritis Rheum 1999;42:1010-16. (Pubitemid 29215013)
17. Martinez A, Fernandez-Arquero M, Balsa A, et al. Primary association of a MICA allele with protection against rheumatoid arthritis. Arthritis Rheum 2001;44:1261-5. (Pubitemid 32537523)
18. López-Arbesu R, Ballina-García FJ, Alperi-López M, et al. MHC class I chain-related gene B (MICB) is associated with rheumatoid arthritis susceptibility. Rheumatology (Oxford) 2007;46:426-30. (Pubitemid 46349929)
19. Mizuki N, Ota M, Kimura M, et al. Triplet repeat polymorphism in the transmembrane region of the MICA gene: a strong association of six GCT repetitions with Behçet disease. Proc Natl Acad Sci U S A 1997;94:1298-303.
20. Sugimura K, Ota M, Matsuzawa J, et al. A close relationship of triplet repeat polymorphism in MHC class I chain-related gene A (MICA) to the disease susceptibility and behavior in ulcerative colitis. Tissue Antigens 2001;57:9-14. (Pubitemid 32151070)
21. Orchard TR, Dhar A, Simmons JD, et al. MHC class I chain-like gene A (MICA) and its associations with inflammatory bowel disease and peripheral arthropathy. Clin Exp Immunol 2001;126:437-40. (Pubitemid 34008715)
22. Amroun H, Djoudi H, Busson M, et al. Early-onset ankylosing spondylitis is associated with a functional MICA polymorphism. Hum Immunol 2005;66:1057-61. (Pubitemid 43005008)
23. Tsuchiya N, Shiota M, Moriyama S, et al. MICA allele typing of HLA-B27 positive Japanese patients with seronegative spondylarthropathies and healthy individuals: differential linkage disequilibrium with HLA-B27 subtypes. Arthritis Rheum 1998;41:68-73. (Pubitemid 28041924)
24. Martinez-Borra J, Gonzalez S, López-Vazquez A, et al. HLA-B27 alone rather than B27-related class I haplotypes contributes to ankylosing spondylitis susceptibility. Hum Immunol 2000;61:131-9. (Pubitemid 30075234)
25. Steinle A, Li P, Morris DL, et al. Interactions of human NKG2D with its ligands MICA, MICB and homologs of the mouse RAE-1 protein family. Immunogenetics 2001;53:279-87. (Pubitemid 32678762)
26. Goto K, Ota M, Maksymowych WP, et al. Association between MICA gene A4 allele and acute anterior uveitis in white patients with and without HLA-B27. Am J Ophthalmol 1998;126:436-41. (Pubitemid 28422070)
27. González S, Brautbar C, Martínez-Borra J, et al. Polymorphism in MICA rather than HLA-B/C genes is associated with psoriatic arthritis in the Jewish population. Hum Immunol 2001;62:632-8. (Pubitemid 32506181)
28. Tamaki S, Kawakami M, Yamanaka Y, et al. Relationship between soluble MICA and the MICA A5.1 homozygous genotype in patients with oral squamous cell carcinoma. Clin Immunol 2009;130:331-7.
29. Groh V, Wu J, Yee C, et al. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature 2002;419:734-8. (Pubitemid 35177960)
30. Muñoz-Saá I, Cambra A, Pallarés L, et al. Allelic diversity and affinity variants of MICA are imbalanced in Spanish patients with Behçet's disease. Scand J Immunol 2006;64:77-82.
31. Marzo-Ortega H, McGonagle D, O'Connor P, et al. Efficacy of etanercept for treatment of Crohn's related spondyloarthritis but not colitis. Ann Rheum Dis 2003;62:74-6. (Pubitemid 36005801)
32. Smale S, Natt RS, Orchard TR, et al. Inflammatory bowel disease and spondylarthropathy. Arthritis Rheum 2001;44:2728-36. (Pubitemid 34016191)